CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market ...
Ionis Pharmaceuticals, Inc. today announced that it will present additional data from the pivotal Phase 3 OASIS and OASISplus studies, as well as three year data from the Phase 2 open-label extension ...
HAE is a life-threatening condition marked by recurrent angioedema attacks in parts of the body including the larynx, face, extremities and abdomen. It is classified under Japan's "primary ...
About Hereditary Angioedema (HAE) HAE is a rare and potentially ... including the hands, feet, genitals, stomach, face and/or throat. HAE is estimated to affect more than 20,000 people in the ...
It wasn’t until late last year, 35 years into its history, that Ionis Pharmaceuticals e | To support the launch of Tryngolza, ...
Since 2022, Twenty-seven-year-old Daniela Powers, a native of West Virginia has experiencing unexplained rashes and swelling ...
Donidalorsen, a potential treatment – preferred treatment for hereditary angioedema later this year ... including severe abdominal pain and cognitive impairment. In the most severe manifestation ...